Sally C. Pipes

Commentary

Bernie’s Not-So-Subtle Single-Payer Plot

Senator Bernie Sanders (I.,Vt.), America’s most prominent proponent of government-run health care, is once again leading the charge to move our country to a single-payer system. As chairman of the Senate Budget Committee, Sanders is pushing a $3.5 trillion budget plan that includes expansions of Medicare, Medicaid, and Obamacare. Some ...
Commentary

Democrats’ Misguided Plan to Expand Medicare Doesn’t Add Up

For weeks, congressional Democrats have been pushing to lower Medicare’s eligibility age from 65 to 60 as part of their $3.5 trillion spending bill. A new paper from the American Action Forum (AAF) by Christopher Holt and Stephen Parente reveals just how radical that change would be. Such an expansion of Medicare would cost ...
Commentary

The FDA’s waiting game is costing children’s lives

This week, Pfizer-BioNTech submitted data to the Food and Drug Administration demonstrating the safety and effectiveness of its COVID-19 vaccine in children ages 5 to 11. The duo is expected to apply for emergency-use authorization in the coming weeks. Federal regulators have promised they’ll “urgently” review the data. The FDA’s ...
Commentary

Drug Price Controls Inflict Worse Harm Than Even Critics Recognize

It’s no secret that H.R. 3 — the Democrats’ plan to impose price controls on prescription drugs — would have devastating consequences for our healthcare sector. After all, artificially restricting the price of any product invariably leads to shortages, rationing, and a slowdown in both investment and innovation. A new ...
Commentary

As Democrats Push Single-Payer, Brits Hope To Escape It

A record 5.6 million patients in the United Kingdom are currently on waiting lists for hospital care. That’s equivalent to nearly one in 10 Britons. Of that group, about 300,000 have been waiting at least one year for treatment. Those who can afford to are increasingly paying out of pocket for private care. More than ...
Commentary

Slow FDA approvals of at-home rapid tests have prolonged the pandemic

The delta variant has wreaked havoc. This week, the U.S. reported a seven-day average of more than 146,000 daily cases . In total, COVID-19 has killed more than 660,000 Americans since the start of the pandemic. Thankfully, the rate of increase appears to be falling in many areas, compared to ...
Commentary

Biden’s Prescription Drug Plan Is Nothing More Than Price Controls

The Biden administration’s “Comprehensive Plan for Addressing High Drug Prices,” released last week, paints a vivid picture of the difficulties patients face affording their medicines. “Americans pay too much for prescription drugs,” the report notes. “Many Americans do not take medications as prescribed because of their cost.” How does the administration intend to ...
Commentary

Another Warning About Medicare Is Going Unheeded

The annual report from Medicare’s trustees just arrived. The picture it paints is anything but sunny. According to the report, Medicare’s Part A hospital insurance trust fund is set to be exhausted in 2026. Avoiding this fate, the trustees conclude, will require a massive increase in taxes or decrease in ...
Medicaid

Democrats’ Latest Attempt To Expand Medicare Would Hurt Seniors

As part of their $3.5 trillion budget plan, Democrats hope to expand Medicare to include, among other additions, coverage for dental benefits by 2028. It’s a dream progressives have been pursuing for years. Sen. Bernie Sanders, I-Vt., called for the changes in his 2016 and 2020 presidential campaign platforms. House Speaker Nancy ...
Commentary

Under Dems’ Drug Pricing Plan, Dozens of New Meds Will Never Be Invented

The Congressional Budget Office just released an analysis of House Democrats’ effort to impose price controls on prescription drugs, H.R. 3 — the Elijah E. Cummings Lower Drug Costs Now Act. The CBO’s chief finding is grim. By drastically limiting pharmaceutical revenue, H.R. 3 would starve scientists of the funding they need ...
Commentary

Bernie’s Not-So-Subtle Single-Payer Plot

Senator Bernie Sanders (I.,Vt.), America’s most prominent proponent of government-run health care, is once again leading the charge to move our country to a single-payer system. As chairman of the Senate Budget Committee, Sanders is pushing a $3.5 trillion budget plan that includes expansions of Medicare, Medicaid, and Obamacare. Some ...
Commentary

Democrats’ Misguided Plan to Expand Medicare Doesn’t Add Up

For weeks, congressional Democrats have been pushing to lower Medicare’s eligibility age from 65 to 60 as part of their $3.5 trillion spending bill. A new paper from the American Action Forum (AAF) by Christopher Holt and Stephen Parente reveals just how radical that change would be. Such an expansion of Medicare would cost ...
Commentary

The FDA’s waiting game is costing children’s lives

This week, Pfizer-BioNTech submitted data to the Food and Drug Administration demonstrating the safety and effectiveness of its COVID-19 vaccine in children ages 5 to 11. The duo is expected to apply for emergency-use authorization in the coming weeks. Federal regulators have promised they’ll “urgently” review the data. The FDA’s ...
Commentary

Drug Price Controls Inflict Worse Harm Than Even Critics Recognize

It’s no secret that H.R. 3 — the Democrats’ plan to impose price controls on prescription drugs — would have devastating consequences for our healthcare sector. After all, artificially restricting the price of any product invariably leads to shortages, rationing, and a slowdown in both investment and innovation. A new ...
Commentary

As Democrats Push Single-Payer, Brits Hope To Escape It

A record 5.6 million patients in the United Kingdom are currently on waiting lists for hospital care. That’s equivalent to nearly one in 10 Britons. Of that group, about 300,000 have been waiting at least one year for treatment. Those who can afford to are increasingly paying out of pocket for private care. More than ...
Commentary

Slow FDA approvals of at-home rapid tests have prolonged the pandemic

The delta variant has wreaked havoc. This week, the U.S. reported a seven-day average of more than 146,000 daily cases . In total, COVID-19 has killed more than 660,000 Americans since the start of the pandemic. Thankfully, the rate of increase appears to be falling in many areas, compared to ...
Commentary

Biden’s Prescription Drug Plan Is Nothing More Than Price Controls

The Biden administration’s “Comprehensive Plan for Addressing High Drug Prices,” released last week, paints a vivid picture of the difficulties patients face affording their medicines. “Americans pay too much for prescription drugs,” the report notes. “Many Americans do not take medications as prescribed because of their cost.” How does the administration intend to ...
Commentary

Another Warning About Medicare Is Going Unheeded

The annual report from Medicare’s trustees just arrived. The picture it paints is anything but sunny. According to the report, Medicare’s Part A hospital insurance trust fund is set to be exhausted in 2026. Avoiding this fate, the trustees conclude, will require a massive increase in taxes or decrease in ...
Medicaid

Democrats’ Latest Attempt To Expand Medicare Would Hurt Seniors

As part of their $3.5 trillion budget plan, Democrats hope to expand Medicare to include, among other additions, coverage for dental benefits by 2028. It’s a dream progressives have been pursuing for years. Sen. Bernie Sanders, I-Vt., called for the changes in his 2016 and 2020 presidential campaign platforms. House Speaker Nancy ...
Commentary

Under Dems’ Drug Pricing Plan, Dozens of New Meds Will Never Be Invented

The Congressional Budget Office just released an analysis of House Democrats’ effort to impose price controls on prescription drugs, H.R. 3 — the Elijah E. Cummings Lower Drug Costs Now Act. The CBO’s chief finding is grim. By drastically limiting pharmaceutical revenue, H.R. 3 would starve scientists of the funding they need ...
Scroll to Top